Clinical activity of the <scp>MEK</scp> inhibitor trametinib in metastatic melanoma containing <i><scp>BRAF</scp></i> kinase fusion — Alexander M. Menzies (2015) | RDL Network
Helen Rizos, Alexander M. Menzies, Gulietta M. Pupo, Matteo S. Carlino, Carina Fung, Jessica Hyman, Lauren E. Haydu, Branka Mijatov, Therese M. Becker, Suzanah C. Boyd, Julie R. Howle, Robyn P.M. Saw, John F. Thompson, Richard Kefford, Richard A Scolyer, Georgina V. Long
Alexander M. Menzies, James S. Wilmott, Martin Drummond, Serigne Lo, Megan Lyle, Matthew Chan, John F. Thompson, Alex Guminski, Matteo S. Carlino, Richard A Scolyer, Richard Kefford, Georgina V. Long
Matteo S. Carlino, Vu Kwan, David K. Miller, Catherine A.B. Saunders, Desmond Yip, Adnan Nagrial, Jeanne Tomlinson, Sean M. Grimmond, Richard A Scolyer, Richard Kefford, Andrew V. Biankin, Georgina V. Long
Helen Rizos, Alexander M. Menzies, Gulietta M. Pupo, Matteo S. Carlino, Carina Fung, Jessica Hyman, Lauren E. Haydu, Branka Mijatov, Therese M. Becker, Suzanah C. Boyd, Julie R. Howle, Robyn P.M. Saw, John F. Thompson, Richard F. Kefford, Richard A Scolyer, Georgina V. Long
Discussion(0)
No comments yet. Be the first to comment.